Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) PT at $9.88

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been given a consensus recommendation of "Buy" by the six analysts that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $9.88.

Several research analysts recently weighed in on BIOX shares. Lake Street Capital dropped their price objective on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a research report on Friday, February 7th. Canaccord Genuity Group cut their price target on Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research note on Thursday, February 13th. Finally, Oppenheimer lowered their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating for the company in a research report on Tuesday, January 28th.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX traded down $0.12 during trading on Friday, reaching $4.37. The company had a trading volume of 19,358 shares, compared to its average volume of 160,422. Bioceres Crop Solutions has a 52 week low of $3.69 and a 52 week high of $13.18. The business's 50 day moving average price is $5.12 and its 200-day moving average price is $6.32. The stock has a market cap of $274.05 million, a PE ratio of 218.61 and a beta of 0.73. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.96 and a current ratio of 1.33.

Remove Ads

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of institutional investors and hedge funds have recently added to or reduced their stakes in BIOX. Stifel Financial Corp boosted its holdings in Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock worth $321,000 after buying an additional 10,224 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock valued at $708,000 after acquiring an additional 29,693 shares during the period. Ping Capital Management Inc. boosted its stake in Bioceres Crop Solutions by 7.3% during the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock worth $268,000 after acquiring an additional 3,000 shares during the last quarter. Fourth Sail Capital LP grew its holdings in Bioceres Crop Solutions by 16.6% during the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock valued at $22,490,000 after purchasing an additional 527,859 shares during the period. Finally, Ballast Asset Management LP increased its stake in Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock valued at $2,620,000 after purchasing an additional 82,187 shares in the last quarter. Institutional investors own 17.68% of the company's stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.